The amyloidogenic processing pathway of the APP (amyloid precursor protein) generates Aβ (amyloid β-peptide), the major constituent in Alzheimer's disease senile plaques. This processing is catalysed by two unusual membrane-localized aspartic proteinases, β-secretase [BACE1 (β-site APP-cleaving enzyme 1)] and the γ -secretase complex. There is a clear link between APP processing and copper homoeostasis in the brain. APP binds copper and zinc in the extracellular domain and Aβ also binds copper, zinc and iron. We have found that a 24-residue peptide corresponding to the C-terminal domain of BACE1 binds a single copper(I) atom with high affinity through cysteine residues. We also observed that the cytoplasmic domain of BACE1 interacts with CCS, the dedicated copper chaperone for SOD1 (superoxide dismutase 1). Overproduction of BACE1 reduces SOD1 activity in cells. Consequently, SOD1 activity, cytosolic copper and ectodomain cleavage of APP are linked through BACE1.
Introduction
Dysregulation of metal homoeostasis and neurodegeneration are clearly linked in a number of neurodegenerative diseases including high-profile diseases such as Alzheimer's and Parkinson's, as well as the less common diseases including Freidrich's ataxia and prion disease [1] . In Alzheimer's disease, the current consensus is that the accumulation of Aβ (amyloid β-peptide), probably in an intracellular oligomeric form, is neurotoxic and initiates a cascade of pathological events [2] . Ultimately, this leads to the synaptic and neuronal loss which underlies dementia. Metals appear to be intimately involved in this process, but the details are only partially elucidated [3] . However, the following facts are clear: APP (amyloid precursor protein), from which Aβ is derived, binds copper and zinc in the extracellular domain [4] . The aggregation of Aβ in vitro is metal-dependent, and senile plaques contain high levels of copper, zinc and iron [5] . Overexpression of APP in both animal models and cell-based systems leads to a reduction in intracellular copper levels, with little effect on zinc levels [6] . Administration of metal chelators such as Clioquinol (iodochlorhydroxyquin) to mouse models of Alzheimer's disease leads to the clearance of amyloid plaques [7] . However, recent data suggests that this may be due to the up-regulation of proteolytic degradation of Aβ rather than to the abstraction of metal from the plaque [8] .
What is the role of metal in the brain? There is clear evidence that metals, particularly zinc, are neuromodulators, acting as allosteric effectors of neurotransmitter receptor responses [9] . This is consistent with the long-standing evidence that zinc and copper are released into the synaptic cleft to reach high micromolar concentrations [10] . This has been interpreted as showing that copper and zinc were released in a free unbound state. However, this has recently been challenged, since the fluorescent probes used in subsequent studies perturb the metal-binding equilibrium, suggesting that metals are never 'free', but are always protein-bound [11] . Increased synaptic activity increases Aβ release and metalbound Aβ may have a role in synaptic function [12] . The current model is that Aβ is released at the synapse; this may be in a metal-bound form or, given its high affinity for metals, it could act as a scavenger in the synaptic cleft [3] . In the normal brain, Aβ is cleared rapidly; its half-life in the cerebrospinal fluid is approx. 15 min [13] . However, there is an agedependent decline in the efficiency of Aβ clearance which is postulated to lead to the accumulation of hypermetalated Aβ, which promotes the formation of reactive oxygen species [3] . Therefore further investigation of metal homoeostasis in relation to Aβ accumulation is essential to advance our understanding of the early pathogenesis of Alzheimer's disease.
BACE1 (β-site APP-cleaving enzyme 1) catalyses the rate-limiting step in the amyloidogenic processing of APP, and its activity determines the amount of Aβ released from cells. We set out to determine whether BACE1 is involved in copper homoeostasis and the regulation of the responses to oxidative stress by a combination of copper-binding and protein-protein interaction studies.
BACE1 binds copper
The cytoplasmic domain of BACE1 is a 24-amino-acid segment that contains an endosomal retrieval motif and a phosphorylation site by which trafficking is controlled [14, 15] . The sequence CQWRCLRCLRQQHDDFADDISLLK 501 contains three cysteine residues which have been shown to be palmitoylated, although the precise role of this fatty acid modification is still unclear [16] . We reasoned that these amino acids might constitute a copper(I)-binding site and were able to show that a synthetic peptide was able to bind a single copper atom with high affinity, through thiolate ligands [17] . This was evident from the clear saturable increase in absorbance at 265 nm in the presence of increasing concentrations of copper(I). These experiments indicated a stoichiometry of 1, and the results of competition experiments with bathocuproine disulfonate are consistent with a dissociation constant of 10 −19 M. By using a series of peptides in which the cysteine residues were changed to alanine, individually and in combination, we were able to determine that the central cysteine of the three (amino acid 482 in the 501-amino-acid isoform of BACE1) plays a key role in metal binding. Furthermore, we demonstrated that the same wildtype peptide binds zinc, but with an affinity which is much lower than that of copper. In direct mixing experiments, where the peptide was incubated with equimolar concentrations of zinc and copper(I), copper-peptide complexes with a 1:1 stoichiometry were detected, but no zinc complexes [17] .
While these experiments demonstrate that the BACE1 cytoplasmic domain peptide binds copper(I) with high affinity and specificity, we await confirmation that this occurs in vivo.
BACE1 binds to CCS, the copper chaperone for SOD1 (superoxide dismutase 1)
Within the cell, the total copper concentration is estimated to be 70 µM, but the concentration of 'free' copper is less than 0.1 nM, indicating that there is no free copper within the cell [18] . This is due to the presence of highly specific copper chaperones which accept metal from the plasma membrane transporter and deliver it to target proteins ( Table 1) . To identify the chaperone that delivers copper to BACE1, we conducted a yeast two-hybrid screen using the cytoplasmic domain of BACE1 as bait and discovered a specific interaction with CCS [17] . This was confirmed by the successful immunoprecipitation of BACE1 from rat brain using CCSspecific antibodies. Most dramatically, we could visualize the co-migration of dsRed-tagged CCS protein and GFP (green fluorescent protein)-tagged BACE1 down the axons of rat primary cortical neurons indicating a stable association of cytosolic CCS with membrane-bound BACE1.
CCS is essential for the activation of SOD1, delivering copper by a mechanism that requires molecular oxygen [19] . We found that, by overproducing BACE1 in CHO (Chinesehamster ovary) cells, the activity of SOD1 in cell extracts was reduced. This activity could be restored by overexpression of CCS. These results raise the question of how high levels of BACE1 might bring about a reduction in SOD1 activity in cells. As SOD1 is in excess of CCS in cells [20] , our direct binding experiments suggest a simple sequestration model in which the presence of high levels of BACE1 causes binding to CCS, limiting the amount of CCS available for SOD1 activation. Although this is consistent with our findings, it is inconsistent with the observations that CCS acts catalytically and interacts with SOD1 transiently [21] , hence there should always be sufficient CCS available to activate SOD1, albeit at a reduced rate. Alternatively, BACE1 could inhibit the activation pathway directly [19] . In this pathway, CCS binds copper(I) through residues in domains I and III. This enhances the binding of CCS to Zn-SOD1, leading to the formation of a non-covalent heterodimeric CCS-SOD1 complex via domain II of CCS. The next step is the oxygen-dependent formation of an intermolecular disulfide bond to produce a covalently linked heterodimer. The subsequent steps are less clearly defined, but it is predicted to involve a disulfide isomerization reaction and copper insertion to form active Cu/Zn-SOD1 [19] . Since we have established that BACE1 interacts with domain I of CCS it could therefore prevent the formation of copper-bound CCS and thereby inhibit activation of SOD1.
There is an intriguing link between APP and BACE1 in the context of CCS binding. The cytoplasmic domain of APP binds to the X11 family of proteins [22] . There is evidence that X11α and X11β have a range of functions, including protein trafficking and copper homoeostasis [23] . It has been shown that X11α interacts directly with CCS via domain III. Interestingly, overexpression of X11α reduces SOD1 activity which, in turn, is restored by overexpression of CCS. This suggests the existence of a quaternary complex of APP, BACE1, Xllα and CCS (Figure 1 ). Through this complex, the activity of BACE1 or its association with APP could be regulated by intracellular copper levels or the redox state of the cytosol. For example, under conditions of high intracellular copper and increased oxidative stress, BACE1 cleavage of APP could be increased, leading to the release of copper from the cell bound to the extracellular domain or to Aβ. Further investigation should yield some valuable insights into the role of this key aspartic proteinase in neuronal metal homoeostasis. 
